Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adevit is a specialized dietary supplement developed by Laboratorios Luar, specifically designed for the nutritional management of patients with cystic fibrosis and other conditions associated with fat-soluble vitamin malabsorption. The formulation provides a comprehensive blend of fat-soluble vitamins (A, D, E, and K) in combination with essential trace elements, including zinc and selenium, and the antioxidant coenzyme Q10. By addressing the specific malabsorptive challenges faced by individuals with pancreatic insufficiency, Adevit helps prevent nutritional deficiencies and supports overall antioxidant status and metabolic function. It is currently approved and marketed for use in gastroenterology and cystic fibrosis care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Adevit.